NCT06165159

Brief Summary

Influence of the type of treatment for type 1 diabetes (pump versus multiple injections versus closed loop) on the treatment burden of children and adolescents and their parents.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 23, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

December 11, 2023

Status Verified

December 1, 2023

Enrollment Period

5 months

First QC Date

November 23, 2023

Last Update Submit

December 8, 2023

Conditions

Keywords

Type 1 diabetesChildrenAdolescentsParentsPumpMultiple injectionsClosed loopBurden of treatmentQuality of life

Outcome Measures

Primary Outcomes (1)

  • The primary outcome corresponds to the score obtained after completing the study questionnaire. The questionnaire is completed at the participation agreement.

    The primary outcome is the treatment burden according to the treatment modality (semi-closed loop versus insulin pump versus multi-injection) assessed using a specific questionnaire

    1 day

Interventions

"Children over the age of 8 with type 1 diabetes diagnosed more than 6 months ago in France, followed in one of the hospitals that are members of the Aide aux Jeunes Diabétiques (AJD) association. Parents or people involved in the day-to-day life of children with type 1 diabetes diagnosed at least 6 months ago, whose child is being followed in France in one of the hospitals affiliated to the AJD association."

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be recruited from the national network of the Association d'Aide aux Jeunes Diabetiques (AJD). The AJD federates local patient associations, which are regularly asked to distribute questionnaires to their members.

You may qualify if:

  • Children over the age of 8 whose type 1 diabetes has been diagnosed for at least 6 months
  • Parents or people involved in the day-to-day life of children with type 1 diabetes who have been diagnosed for at least 6 months

You may not qualify if:

  • Parents not involved in managing their child's type 1 diabetes (child in care)
  • Have already completed the questionnaire (one questionnaire completed per child and their parents or family caregivers)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emmanuelle LABARRE

Angers, 49000, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Emmanuelle LABARRE

    Angers University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2023

First Posted

December 11, 2023

Study Start

January 1, 2024

Primary Completion

June 1, 2024

Study Completion

September 1, 2024

Last Updated

December 11, 2023

Record last verified: 2023-12

Locations